At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 26 enrolled
Drug / intervention
Ethanol +1 moredrug
Likely dose
Glucagon 50 microgramsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Ethanol Intoxication on the Anti-hypoglycemic Action of Glucagon
In Brief
A Phase 4 clinical trial evaluating Ethanol and Glucagon for Type 1 Diabetes Mellitus. Completed, enrolled 26 participants across 1 site.
Detailed Summary
This study will test the hypothesis that a BAC (blood alcohol content) of 0.1% will not significantly alter the anti-hypoglycemic effect of mico-dose glucagon in individuals with type 1 diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 2015
Enrollment StartMar 2016
Primary CompletionMay 2017
Study CompletionJun 2017
TodayJul 2026
First PostedAug 5, 2015
Enrollment StartMar 1, 2016
Primary CompletionMay 1, 2017
Study CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.9 years ago
Interventions
Ethanoldrug
IV infusion of ethanol to stabilize BAC (blood alcohol content) at 0.1%
Glucagondrug
injection of 50 micrograms of glucagon